EU CMO market to top $20bn as big pharma ups outsourcing
A patent loss-fuelled surge in big pharma outsourcing will push the European CMO market through the $20bn barrier by 2018, analysis claims.
Archives for January 25, 2012
UPDATE
Manufacturing round-up: new facilities in India
in-PharmaTechnologist presents its round-up of the latest manufacturing headlines including new facilities for Aptar and Granules, and some good news for Swiss Novartis workers.
An experienced CMO is key to successful biologics development says Cobra Biologics
Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.
Vivalis grows sales as demand for vaccine cell line increases
Vivalis nearly doubled revenues from its vaccine production platform in 2011 and has inked a third mAb discovery programme with Sanofi.
Plummeting profits prompt Lonza to fire CEO
Lonza has fired its CEO after a halving of net income prompted the board to find another leader for “the challenging years ahead”.
Albermarle cites favourable pricing and pharma sales as factor in Q4 rev growth
Ibuprofen API maker Albemarle says favourable volumes and pricing helped drive gains made by fine chemicals unit in Q4.
Ashland investing in capacity, raising prices in ISP integration
Ashland is investing in production assets and raising prices as it looks to get the most from its $3.2bn acquisition.
CFS plans to tackle financial management diversity in different countries through expansion
Clinical Financial Services (CFS) has made its first foray into the global market after opening a new office in Edinburgh, Scotland.